Melody A. Cobleigh, MD

Melody A. Cobleigh, MD’s national service has included leadership positions on the Breast Cancer Committee of the American Society of Clinical Oncology, the Patient Advocacy Committee, the Health Services Research Committee and three terms on the editorial board of the Journal of Clinical Oncology. She currently serves on the core committee of NRG, an international clinical trial network. With a primary clinical and research interest in breast cancer, Cobleigh has published articles on treatment of breast cancer using monoclonal antibody, endocrine, retinoid, antiangiogenesis, antisense, immunotherapy, tumor vaccine and chemotherapies. A major focus of her work is bridging the gap between the clinic and the laboratory bench in understanding the biology of breast disease and the mechanisms of resistance and sensitivity to targeted therapies. She has also published on issues related to quality of life in breast cancer survivors.